Cargando…
A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and Chemogenomics
Publicly available compound and bioactivity databases provide an essential basis for data-driven applications in life-science research and drug design. By analyzing several bioactivity repositories, we discovered differences in compound and target coverage advocating the combined use of data from mu...
Autores principales: | Isigkeit, Laura, Chaikuad, Apirat, Merk, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028877/ https://www.ncbi.nlm.nih.gov/pubmed/35458710 http://dx.doi.org/10.3390/molecules27082513 |
Ejemplares similares
-
Chemical Starting Matter for HNF4α Ligand Discovery and Chemogenomics
por: Meijer, Isabelle, et al.
Publicado: (2020) -
Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening
por: Tjaden, Amelie, et al.
Publicado: (2022) -
Chemogenomic profiling to understand the antifungal action of a bioactive aurone compound
por: Alqahtani, Fatmah M., et al.
Publicado: (2019) -
Targeting the Alternative
Vitamin E Metabolite Binding
Site Enables Noncanonical PPARγ Modulation
por: Arifi, Silvia, et al.
Publicado: (2023) -
Semantic inference using chemogenomics data for drug discovery
por: Zhu, Qian, et al.
Publicado: (2011)